 BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to :
-Fight antimicrobials resistance.
-Improve vaccines safety and efficacy.
-Quickly diagnose infections at patient bedside.
-take full advantage to human and animal microbiota.

In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units.
Each project strives on academic research excellence and is undertaken by a team of high-level experts and engineers, which benefits from state-of-the-art equipment, technological infrastructures.

BIOASTER, an independent non-profit organization, is one of 8 French TRIs  created in 2012 on the initiative of the French Government through the “Investments for the Future” program. The two historical founders are Lyonbiopôle (a biocluster, the one-stop shop for healthcare innovation in Rhône-Alpes, France) and the Institut Pasteur in Paris. They were joined from the beginning by the CNRS, the INSERM, the CEA, Mérieux Institute, Danone Nutricia Research and Sanofi Pasteur -and newly joined by bioMérieux- to create a unique Technology Institute dedicated to infectious diseases and microbiology in health. The Institute benefits from the support of Lyon Métropole and the  Region Auvergne Rhône Alpes and the dynamism of a group of 40 SMEs in the Lyon and Paris regions. 

Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries.

More information on www.bioaster.org

Biotechnology

Health Care

Life Sciences

BIOASTER

Viet-Dung Tran

Christine Pohl

Cyril Guyard

Erwin Sentausa

Alexandre Moulin

Derry Mercer

Lucie Saint-Joanis

Adrien Saliou

Xavier Morge

The Microbiology and Antimicrobial Research team at BIOASTER focuses on pioneering research to combat antimicrobial resistance and enhance vaccine efficacy. Comprising leading experts in microbiology and infectious diseases, the team conducts collaborative projects with academic and industrial partners, utilizing advanced technologies to develop rapid diagnostic tools and leverage insights from human and animal microbiota. Their work aims to address critical challenges in public health and improve patient outcomes through innovation and scientific excellence.

Microbiology and Antimicrobial Research

Research and Development Specialists

Research and Development

Microbiology and Antimicrobial Research

About

Team members

Other teams at BIOASTER

Research and Development Specialists

Research and Development